| Title: |
Cannabis Use Is Inversely Associated with Overweight and Obesity in Hepatitis B Virus-Infected Patients (ANRS CO22 Hepather Cohort) |
| Authors: |
Barré, Tangui; Pol, Stanislas; Ramier, Clémence; Di Beo, Vincent; Carrat, Fabrice; Bureau, Morgane; Bourlière, Marc; Dorival, Céline; Serfaty, Lawrence; Asselah, Tarik; Boursier, Jérôme; Marcellin, Fabienne; Carrieri, Patrizia; Fontaine, Hélène; Protopopescu, Camelia; Alric, Laurent; Bonnet, Delphine; Payssan-Sicart, Virginie; Pomes, Chloe; Zoulim, Fabien; Maynard, Marianne; Bai, Roxane; Hucault, Lucie; Bailly, François; Raffi, François; Billaud, Eric; Boutoille, David; Lefebvre, Maeva; André-Garnier, Elisabeth; Cales, Paul; Hubert, Isabelle; Lannes, Adrien; Lunel, Françoise; Boyer, Nathalie; Giuily, Nathalie; Castelnau, Corinne; Scoazec, Giovanna; Rousseaud, Emilie; Vallet-Pichard, Anaïs; Sogni, Philippe; Ledinghen, Victor De; Foucher, Juliette; Hiriart, Jean-Baptiste; M'Bouyou, Jancell; Irlès-Depé, Marie; Si Ahmed, Si Nafa; Oules, Valérie; Tran, Albert; Anty, Rodolphe; Gelsi, Eve; Truchi, Régine; Thabut, Dominique; Hammeche, Saloua; Moussali, Joseph; Causse, Xavier; Dieuleveult, Barbara De; Ouarani, Brahim; Labarrière, Damien; Ganne, Nathalie; Grando-Lemaire, Véronique; Nahon, Pierre; Brulé, Séverine; Ulker, Betul; Guyader, Dominique; Jezequel, Caroline; Brener, Audrey; Laligant, Anne; Rabot, Aline; Renard, Isabelle; Habersetzer, François; Baumert, Thomas; Doffoel, Michel; Mutter, Catherine; Simo-Noumbissie, Pauline; Razi, Esma; Bronowicki, Jean-Pierre; Barraud, Hélène; Bensenane, Mouni; Nani, Abdelbasset; Hassani-Nani, Sarah; Bernard, Marie-Albertine; Pageaux, Georges-Philippe; Larrey, Dominique; Meszaros, Magda; Metivier, Sophie; Bureau, Christophe; Morales, Thibault; Peron, Jean Marie; Robic, Marie Angèle; Decaens, Thomas; Faure, Marine; Froissart, Bruno; Hilleret, Marie-Noelle; Zarski, Jean-Pierre; Riachi, Ghassan; Goria, Odile; Paris, Fatima; Montialoux, Hélène; Leroy, Vincent; Amaddeo, Giuliana; Varaut, Anne; Simoes, Mélanie; Amzal, Rachida; Chazouillières, Olivier; Andreani, Tony; Angoulevant, Bénédicte; Chevance, Azeline; Samuel, Didier; Antonini, Teresa; Coilly, Audrey; Duclos Vallée, Jean-Charles; Tateo, Mariagrazia; Abergel, Armand; Reymond, Maud; Brigitte, Chanteranne; Benjamin, Buchard; Muti, Léon; Geist, Claire; Conroy, Guillaume; Riffault, Raphaëlle; Rosa, Isabelle; Barrault, Camille; Costes, Laurent; Hagège, Hervé; Loustaud-Ratti, Véronique; Carrier, Paul; Debette-Gratien, Maryline; Mathurin, Philippe; Lassailly, Guillaume; Lemaitre, Elise; Canva, Valérie; Dharancy, Sébastien; Louvet, Alexandre; Minello, Anne; Latournerie, Marianne; Bardou, Marc; Mouillot, Thomas; d'Alteroche, Louis; Barbereau, Didier; Nicolas, Charlotte; Elkrief, Laure; Jaillais, Anaïs; Gournay, Jérôme; Chevalier, Caroline; Archambeaud, Isabelle; Habes, Sarah; Portal, Isabelle; Gelu-Simeon, Moana; Saillard, Eric; Lafrance, Marie-Josée; Catherine, Lucie |
| Contributors: |
Nutrition, obésité et risque thrombotique (NORT); Institut National de la Recherche Agronomique (INRA)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM); Service d'hépatologie médicale CHU Cochin; Hôpital Cochin AP-HP; Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP); Sciences Economiques et Sociales de la Santé & Traitement de l'Information Médicale (SESSTIM - U1252 INSERM - Aix Marseille Univ - UMR 259 IRD); Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM); ESIM - Déterminants Sociaux de la Santé et du Recours aux Soins (DS3); Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM); Service d'hépato-gastro-entérologie; Assistance Publique - Hôpitaux de Marseille (APHM); Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP); Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU); Hôpital de Hautepierre Strasbourg; Hôpitaux Universitaires de Strasbourg (HUS); Service d’Hépatologie Hôpital Beaujon; Hôpital Beaujon AP-HP |
| Source: |
ISSN: 2578-5125 ; Cannabis and Cannabinoid Research ; https://univ-angers.hal.science/hal-03417059 ; Cannabis and Cannabinoid Research, 2021, ⟨10.1089/can.2021.0094⟩ ; https://www.liebertpub.com/doi/10.1089/can.2021.0094. |
| Publisher Information: |
CCSD; Mary Ann Liebert Inc |
| Publication Year: |
2021 |
| Subject Terms: |
Hepatitis B virus; cannabis; obesity; overweight; socioeconomic status; [SDV]Life Sciences [q-bio] |
| Description: |
International audience ; Background: Chronic hepatitis B virus (HBV) infection may evolve into cirrhosis and hepatocellular carcinoma, and this progression may be accelerated by specific risk factors, including overweight and obesity. Although evidence for a protective effect of cannabis use on elevated body weight has been found for other populations, no data are available for HBV-infected patients.Aims: We aimed to identify risk factors (including cannabis use) for overweight and obesity in patients with HBV chronic infection.Methods: Using baseline data from the French ANRS CO22 Hepather cohort, we performed two separate analyses, one using “central obesity” (based on waist circumference) and the other “overweight” and “obesity” (based on body mass index) as outcomes. Logistic and multinomial regressions were used to model central obesity and overweight/obesity, respectively.Results: Among the 3706 patients in the study population, 50.8% had central obesity, 34.7% overweight, and 14.4% obesity. After multivariable adjustment, current cannabis use was associated with a 59% lower risk of central obesity compared with no lifetime use (adjusted odds ratio [95% CI]: 0.41 [0.24 to 0.70]). It was also associated with a 54% and 84% lower risk of overweight (adjusted relative risk ratio [95% CI]: 0.46 [0.27 to 0.76]) and obesity (0.16 [0.04 to 0.67]), respectively.Conclusions: Cannabis use was associated with lower risks of overweight and obesity in patients with HBV chronic infection. Future studies should test whether these potential benefits of cannabis and cannabinoid use translate into reduced liver disease progression in this high-risk population. |
| Document Type: |
article in journal/newspaper |
| Language: |
English |
| DOI: |
10.1089/can.2021.0094 |
| Availability: |
https://univ-angers.hal.science/hal-03417059; https://univ-angers.hal.science/hal-03417059v1/document; https://univ-angers.hal.science/hal-03417059v1/file/hal-03417059.pdf; https://doi.org/10.1089/can.2021.0094 |
| Rights: |
https://about.hal.science/hal-authorisation-v1/ ; info:eu-repo/semantics/OpenAccess |
| Accession Number: |
edsbas.4281FEB8 |
| Database: |
BASE |